Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2008

01-10-2008 | Research Article

People’s views on the level of agreement of generic medicines for different illnesses

Authors: Maria João Figueiras, Dália Marcelino, Maria Armanda Cortes

Published in: International Journal of Clinical Pharmacy | Issue 5/2008

Login to get access

Abstract

Objectives The present study aims to investigate (1) what is the influence of illness labels (flu, asthma and angina pectoris) upon the level of agreement with the prescription of generic medicines, and (2) the influence of socio-demographic factors on lay beliefs about generic medicines, in general, and for different illness labels. Method This was a cross-sectional design in which the participants were Portuguese, men and women, aged over 18 years old, and recruited from the general population (non-patients). The participants completed an anonymous self-administered questionnaire which included measures of lay beliefs about generic medicines in general (GMS), level of agreement with the prescription of a generic medicines for different illnesses, and socio-demographic factors. Main outcome measure Level of agreement with the use of generic medicines for flu, asthma and angina pectoris. Results Participants seemed to have well-defined beliefs about generics concerning their efficacy and similarity with brand medicines. Beliefs about the efficacy of generic medicines were significantly different according to the three age groups (18–25 years, mean = 3.84 (0.56); 26–37 years, mean = 3.80 (0.61); >38 years, mean = 3.72 (0.66); F = 4.4; P = 0.01), and level of education attained (9 years, mean = 3.60 (0.69); 12 years, mean = 3.78 (0.57); graduate, mean = 3.93 (0.54); F = 32.2; P = 0.000). Although participants have a moderate level of agreement with the prescription of generic medicines for the three different illnesses, their agreement significantly decreased when the illness was perceived as more serious. The lay beliefs about generics seemed to moderate the level of agreement with the prescription of a generic medicine. Conclusions Lay beliefs about generic medicines may influence the level of agreement with the prescription of a generic medicine in a general population sample. These results raise important questions concerning the need to consider illness perceptions of lay people and their relationship with perceptions of treatment for different conditions.
Literature
1.
go back to reference Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc. 2000;40(3):378–83. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc. 2000;40(3):378–83.
2.
go back to reference Haas JS, Phillips KA, Gerstenberger E, Seger AC. Potential savings from substituting generic drugs for brand-nane drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med. 2005;142:891–7.PubMed Haas JS, Phillips KA, Gerstenberger E, Seger AC. Potential savings from substituting generic drugs for brand-nane drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med. 2005;142:891–7.PubMed
3.
go back to reference Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472–9.PubMed Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472–9.PubMed
5.
go back to reference Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36. Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36.
6.
go back to reference Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999;47(6):491–5.PubMedCrossRef Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999;47(6):491–5.PubMedCrossRef
7.
go back to reference Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal EA, Patrick-Miller L, Robitaille C. Illness representations: theoretical foundations. In: Petrie KJ, Weinman JA, editors. Perceptions of Health & Illness. Netherlands: Harwood Academic Publishers; 1997. p. 19–45 (ISBN 90-5702-103-X). Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal EA, Patrick-Miller L, Robitaille C. Illness representations: theoretical foundations. In: Petrie KJ, Weinman JA, editors. Perceptions of Health & Illness. Netherlands: Harwood Academic Publishers; 1997. p. 19–45 (ISBN 90-5702-103-X).
8.
go back to reference Britten N. Patients’ ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract. 1994;44:465–8.PubMed Britten N. Patients’ ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract. 1994;44:465–8.PubMed
9.
10.
go back to reference Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Sociol Health Illn. 1988;10:561–78.CrossRef Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Sociol Health Illn. 1988;10:561–78.CrossRef
11.
go back to reference Rao D. Choice of medicine and hierarchy of resort to different health alternatives among Asian Indian migrants in a metropolitan city in the USA. Ethn Health. 2006;11(2):153–67.PubMedCrossRef Rao D. Choice of medicine and hierarchy of resort to different health alternatives among Asian Indian migrants in a metropolitan city in the USA. Ethn Health. 2006;11(2):153–67.PubMedCrossRef
12.
go back to reference Figueiras MJ, Marcelino D, Cortes MA, Horne R, Weinman J.: Crenças de Senso-comum sobre medicamentos genéricos vs. medicamentos de marca: um estudo piloto sobre diferenças de género. Análise Psicológica. 2007;3(XXV):427–37. Figueiras MJ, Marcelino D, Cortes MA, Horne R, Weinman J.: Crenças de Senso-comum sobre medicamentos genéricos vs. medicamentos de marca: um estudo piloto sobre diferenças de género. Análise Psicológica. 2007;3(XXV):427–37.
13.
go back to reference Figueiras MJ, Marcelino D, Cortes MA. Medicamentos genéricos: crenças de senso-comum da população portuguesa. Rev Port Clin Geral. 2007;23:43–51. Figueiras MJ, Marcelino D, Cortes MA. Medicamentos genéricos: crenças de senso-comum da população portuguesa. Rev Port Clin Geral. 2007;23:43–51.
14.
go back to reference Yelkur R, Capella LM. Generic prescription drugs: awareness, attitudes and intentions of elderly consumers. In: Engelland BT, Smart DT, editors. Marketing: foundations for a changing world. Orlando, FL: Southern Marketing Association; 1995. p. 57–60. Yelkur R, Capella LM. Generic prescription drugs: awareness, attitudes and intentions of elderly consumers. In: Engelland BT, Smart DT, editors. Marketing: foundations for a changing world. Orlando, FL: Southern Marketing Association; 1995. p. 57–60.
15.
go back to reference Kjonniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRef Kjonniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRef
16.
go back to reference Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.PubMedCrossRef Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.PubMedCrossRef
Metadata
Title
People’s views on the level of agreement of generic medicines for different illnesses
Authors
Maria João Figueiras
Dália Marcelino
Maria Armanda Cortes
Publication date
01-10-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9247-y

Other articles of this Issue 5/2008

International Journal of Clinical Pharmacy 5/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.